What Is the Price of NeoFipronis (Miaite)
NeoFipronis (Pronidesivir), containing the active ingredient GS-441524, is a groundbreaking oral medication designed specifically for the treatment of Feline Infectious Peritonitis (FIP). FIP is a devastating disease affecting cats worldwide, characterized by symptoms such as inappetence, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomatous inflammation, neurological damage, and uveitis. NeoFipronis offers a highly effective solution for managing these symptoms and improving the quality of life of infected cats.
As the world’s first officially approved FIP treatment by Laos’s Ministry of Agriculture and Forestry (MAF) in March 2026, NeoFipronis has gained recognition for its safety, efficacy, and ease of use. The medication is registered with an official drug registration number, ensuring its quality and regulatory compliance. This innovative treatment is safe, non-invasive, quickly absorbed, and well-tolerated by most cats, with minimal side effects. It provides a promising alternative to traditional, often ineffective, therapies for FIP.
NeoFipronis is administered orally, with dosing tailored to the cat’s weight—typically 15 mg per kilogram of body weight, equivalent to half a tablet. For neurological or ocular forms of FIP, the dosage may be increased to 30 mg/kg under veterinary supervision. Administering the medication once daily, preferably on an empty stomach—either one hour before feeding or two hours after meal—enhances absorption and effectiveness. Continuous treatment for at least 12 weeks is essential for optimal results, and owners must adhere strictly to the prescribed schedule, avoiding missed doses to prevent drug resistance or relapse.
Clinical studies and extensive practical applications have validated the potent antiviral effects of GS-441524, the active component of NeoFipronis. It effectively reduces viral load, alleviates symptoms, and can lead to remission in many cases. Regular monitoring of the cat’s appetite, temperature, mental state, and blood tests—especially liver and kidney functions—is recommended throughout treatment to ensure safety and adjust dosage if needed.
Though NeoFipronis is available as an over-the-counter medication, it is highly advised that pet owners consult a veterinarian before starting treatment. Proper veterinary guidance ensures accurate diagnosis, appropriate dosing, and monitoring for adverse reactions. It is important to purchase NeoFipronis only from authorized sources, such as the official NeoFipronis website, to guarantee product authenticity and quality.
Pricing for NeoFipronis varies depending on regional availability, supplier pricing, and dosage requirements. Since the medication is relatively new, prices are expected to stabilize as distribution expands. Generally, a pack containing sufficient tablets for a 12-week course can range from approximately $200 to $400 USD. Bulk purchasing options and veterinary discounts may be available, and some clinics may offer installment plans or discounts for multiple treatments.
Potential buyers should verify the current price on the official NeoFipronis website or through licensed veterinary pharmacies to ensure they receive genuine and effective medication. As a highly specialized drug for a serious feline disease, the cost reflects its innovative formulation, medical verification, and regulatory approval, making it a valuable investment in a cat’s health and recovery.
In summary, NeoFipronis (Pronidesivir) provides an effective, safe, and innovative approach to managing FIP in cats. Its price may vary, but its therapeutic benefits significantly outweigh costs for many pet owners seeking to combat this challenging disease. Always consult veterinary professionals and purchase through authorized channels to ensure optimal outcomes for your feline companions.
